Physician profile
Garrett C Shepherd
NPI 1609827542
$2,398.76
in general payments reported to CMS, 2019-2025
11 companies · $572 in 2025
The $572 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $101 · 2021: $87.54 · 2022: $478 · 2023: $389 · 2024: $619 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,579.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $928.51 | 2022-2025 | Precision 1, Total30, Dailies |
| Bausch & Lomb Americas INC. | $426.45 | 2022-2025 | Xiidra, Miebo, Infuse |
| Johnson & Johnson Vision Care, INC. | $273.97 | 2019-2025 | Acuvue |
| Abbvie INC. | $176.11 | 2022-2023 | Durysta |
| Allergan, INC. | $146.48 | 2020-2022 | |
| Coopervision INC. | $146.12 | 2022-2025 | Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $130.45 | 2025 | Xdemvy |
| Rxsight INC | $50.12 | 2023 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Carl Zeiss Meditec, INC. | $45.78 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $44.33 | 2019 | |
| Abb Con-Cise Optical Group LLC | $30.44 | 2025 | Spectacle Lenses, Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.